02.08.2013 - British drugmaker AstraZeneca warned on Thursday of higher costs in 2013 as it invests through a slump in sales caused by a wave of patent expiries on key medicines. The prediction...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)